Groundbreaking migraine drug offers instant relief, reduces pain from Day 1
A study reveals that Atogepant, a new migraine prevention drug, offers immediate relief from migraines from the first day of use, significantly reducing migraine occurrences and improving the quality of life for sufferers. The 12-week study assessed safety and effectiveness in people with episodic and chronic migraines.
A study reveals that Atogepant, a new migraine prevention drug, offers immediate relief from migraines from the first day of use, significantly reducing migraine occurrences and improving the quality of life for sufferers. The 12-week study assessed safety and effectiveness in people with episodic and chronic migraines.
